Search
+
    SEARCHED FOR:

    BESSEMER

    Quadria cap picks up minority stake in NephroPlus

    NephroPlus, India's largest dialysis chain, has secured $103 million (₹860 crore) in a Series F funding round led by Quadria Capital. This funding, a mix of fresh capital and a secondary sale, aims to drive expansion plans within India and targeted markets overseas. The primary component of the funding is ₹100 crore. Quadria Capital will become a minority shareholder, valuing NephroPlus at over ₹2,000 crore. Existing investors like Bessemer Venture Partners, International Finance Corporation, and IIFL also participated in the funding round, reducing their stakes.

    Innoviti Technologies to raise Rs 115 crore by April end

    Innoviti Technologies secured funding for mid-market expansion, aiming for profitability by Sep 2024. It provides SaaS tools to enterprise brands like Reliance and plans to initiate IPO proceedings.

    MoveInSync raises $15 million from Bessemer Venture Partners

    MoveInSync, a cab-hailing service provider to enterprises, raised $15M in a Series C funding round from Bessemer Venture Partners. The funding will be used to drive the growth of MoveInSync One, a product that offers cost-effective and seamless commutes for employees. The company's operating model helps optimize electric vehicle utilization for employee commutes.

    Quadria in talks to buy into dialysis chain NephroPlus

    Quadria Capital, an Asia-focused private equity fund, is in talks to acquire a significant minority stake in India's largest dialysis chain, NephroPlus, valued at ₹2,000 crore ($250 million). Existing investors, Bessemer Venture Partners and International Finance Corporation, will exit by selling a 30% stake together, while Investcorp is likely to sell a small stake. NephroPlus, founded in 2009, operates 300+ dialysis centres in over 180 cities across four countries.

    The next phase of growth and innovation for India’s SaaS sector

    Against the backdrop of post-COVID dynamics, the Indian SaaS sector is positioned as a key player in driving digital transformation, with a multitude of factors shaping its future.

    Bessemer, IFC looking to sell 30% stake in dialysis chain NephroPlus

    The US-based Bessemer Venture Partners (BVP) and the World Bank's lending arm International Finance Corporation (IFC) are exploring the sale of about 30% stake in NephroPlus, said multiple people aware of the development. Bessemer and IFC will exit fully by selling about 30% stake together. However, the largest shareholder, Investcorp, is yet to decide on offloading its stake, added sources. Bahrain-based Investcorp owns about 40% stake in NephroPlus.

    The Economic Times
    BACK TO TOP